Scholarlink

Background <p>Sarcopenia, the age-related loss of muscle mass and function, is a growing public health problem. Its multifactorial causes including poor nutrition, physical inactivity, and underlying diseases. Research suggests a role for C-peptide in muscle regulation, but its link to sarcopenia is unclear. We hypothesized that low C-peptide associates with sarcopenia and fractures, and that it promotes myogenesis and protects muscle cells from atrophic damage in vitro.</p> Methods <p>In this cross-sectional study, we analysed data from 191 individuals aged 50 or older, including serum C-peptide and appendicular skeletal muscle mass measurements, along with falls and fractures assessed at follow-up. Skeletal muscle parameters were evaluated using bioelectrical impedance analysis. In parallel, in vitro experiments were performed in C2C12 cells to investigate the effects of C-peptide on myogenic differentiation and its protective role against muscle damage.</p> Results <p>Individuals in the lowest C-peptide tertile had significantly less appendicular skeletal muscle/sarcopenia than those in the highest (<i>p</i> &lt; 0.001). Lower C-peptide significantly increased sarcopenia odds (OR: 0.34; <i>p</i> &lt; 0.001). These individuals also showed higher falls (32%) and fractures (17%) rates compared to the highest tertile (14% and 0%). Fractures were linked to falls and low C-peptide levels (OR: 0.29; <i>p</i> = 0.01). In vitro, C-peptide promotes myogenic differentiation and reduced muscle damage in C2C12 myotubes.</p> Conclusions <p>Our findings suggest the protective role of C-peptide in musculoskeletal health, demonstrating that higher levels are associated with a reduced risk of having low appendicular skeletal muscle mass/sarcopenia and fractures in adults and the elderly. Moreover, C-peptide enhances myogenic differentiation and protects against in vitro nutrient-deprivation muscle damage. Further studies are warranted to explore the therapeutic utility of C-peptide for the prevention of sarcopenia and fractures in adulthood and aging.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

C-peptide promotes myogenic differentiation in vitro and low serum levels are associated with sarcopenia in adults and the elderly

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月11日

查看全文
  • Yvelise Ferro,
  • Alberto Castagna,
  • Samantha Maurotti,
  • Francesca Rita Noto,
  • Elisa Mazza,
  • Valeria Rizzo,
  • Carmelo Pujia,
  • Angelo Galluccio,
  • Angela Sciacqua,
  • Carmine Gazzaruso,
  • Stefano Romeo,
  • Arturo Pujia,
  • Tiziana Montalcini

摘要

Background

Sarcopenia, the age-related loss of muscle mass and function, is a growing public health problem. Its multifactorial causes including poor nutrition, physical inactivity, and underlying diseases. Research suggests a role for C-peptide in muscle regulation, but its link to sarcopenia is unclear. We hypothesized that low C-peptide associates with sarcopenia and fractures, and that it promotes myogenesis and protects muscle cells from atrophic damage in vitro.

Methods

In this cross-sectional study, we analysed data from 191 individuals aged 50 or older, including serum C-peptide and appendicular skeletal muscle mass measurements, along with falls and fractures assessed at follow-up. Skeletal muscle parameters were evaluated using bioelectrical impedance analysis. In parallel, in vitro experiments were performed in C2C12 cells to investigate the effects of C-peptide on myogenic differentiation and its protective role against muscle damage.

Results

Individuals in the lowest C-peptide tertile had significantly less appendicular skeletal muscle/sarcopenia than those in the highest (p < 0.001). Lower C-peptide significantly increased sarcopenia odds (OR: 0.34; p < 0.001). These individuals also showed higher falls (32%) and fractures (17%) rates compared to the highest tertile (14% and 0%). Fractures were linked to falls and low C-peptide levels (OR: 0.29; p = 0.01). In vitro, C-peptide promotes myogenic differentiation and reduced muscle damage in C2C12 myotubes.

Conclusions

Our findings suggest the protective role of C-peptide in musculoskeletal health, demonstrating that higher levels are associated with a reduced risk of having low appendicular skeletal muscle mass/sarcopenia and fractures in adults and the elderly. Moreover, C-peptide enhances myogenic differentiation and protects against in vitro nutrient-deprivation muscle damage. Further studies are warranted to explore the therapeutic utility of C-peptide for the prevention of sarcopenia and fractures in adulthood and aging.